PharmEasy Unlisted Share

₹22

*Average Price as per 4 March, 2024

company-logo

Fundamentals

FACE VALUE

1

BOOK VALUE

9.6

NO OF SHARES

14000000000

EPS

-0.87

SALES

1471.22

INDUSTRY PE

0

DIVIDEND

0

DIVIDEND YIELD

0

PE

-10.8

PB

0.98

PS

8.95

MARKET CAP

13160

EQUITY

1400

PAT

-533.8

MESSAGE

2022-23

OVERVIEW



Pharmeasy’s Product Offerings & Value Chain

API Holdings Ltd aka Pharmeasy is India’s largest digital healthcare platform (based on GMV of products and services sold for the year ended March 31, 2021), according to RedSeer Report.

Pharmeasy operate an integrated, end-to-end business that aims to provide solutions for the healthcare needs of consumers across the following critical stages -

A. providing digital tools and information on illness and wellness,

B. offering teleconsultation,

C. offering diagnostics and radiology tests, and

D. delivering treatment protocols including products and devices.



Pharmeasy has custom-built proprietary technology, unified data platforms, supply chain capabilities, and deep understanding of the dynamic interplay between the various sub-segments of India’s healthcare market are the capabilities that differentiate us. These capabilities enable us to provide each stakeholder in the healthcare value-chain, viz.:

(a) channel (wholesalers, retailers and chemists/institutions),

(b) consultants (and hospitals), diagnostic and radiology labs,

(c) consumers, and

(d) companies (pharmaceutical, nutraceutical, medical devices)

with the technology tools and capabilities to solve their challenges, while also enabling them to benefit from an interconnected network.

Pharmeasy’s Distribution & Presence

Pharmeasy’s businesses have a presence across the country, with last-mile to deliver in over 18,587 pin codes (for June 2021) via PharmEasy marketplace, allowing them the ability to provide access in an affordable manner.

INSIGHT

The Company’s audited standalone and consolidated financial performance for the financial
year ended March 31, 2022 is summarised below


The financial statements of the Company for the financial year 2021-22 are prepared in accordance with Indian Accounting Standards (“Ind AS”), notified under Section 133 of the Companies Act, 2013, (“the Act”) read with the Companies (Accounts) Rules, 2014.



Pharmeasy’s Holistic Presence across the Healtcare Value Chain

Pharmeasy Share Price


Multiple use cases across a consumer’s healthcare journey